Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

252.86 -5.52 (-2.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
EXCLUSIVE: Aurora Cannabis CEO 'Absolutely Confident' Company Will Be EBITDA-Positive By Year's End ↗
Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ: ACB), discussed growing Aurora into the leader of the international medical cannabis market at the Benzinga Cannabis Capital Conference on Wednesday. 
Via Benzinga
News headline image
Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent ↗
The company agreed to the FDA's post-marketing requirements for a depression drug. 
Via Investor's Business Daily
News headline image
Avicanna's Cannabinoid Drugs To Reach Brazil Via Its First 'Big Pharma' Deal ↗
 
Via Benzinga
News headline image
Werewolf Therapeutics Shares Jump On Cancer Product Pact With Jazz Pharma ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2022 ↗
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
News headline image
Syros' CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies ↗
Syros Pharmaceuticals Inc (NASDAQ: SYRS)  
Via Benzinga
News headline image
Expert Ratings For Jazz Pharmaceuticals ↗
Over the past 3 months, 4 analysts have published their opinion on Jazz Pharmaceuticals (NASDAQ:JAZZ) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗
Upgrades 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Raymond James reduced the price target on Intercontinental Exchange, Inc. (NYSE: ICE) from $161 to $157. Intercontinental Exchange shares rose 0.2% to $130.79 in pre-market trading. 
Via Benzinga
News headline image
Why Axsome Therapeutics Stock Is Trading Higher ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ). 
Via Benzinga
News headline image
Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) has  
Via Benzinga
News headline image
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
Jazz Pharmaceuticals's Return On Capital Employed Insights ↗
According to data from Benzinga Pro, during Q4, Jazz Pharmaceuticals's (NASDAQ:JAZZ) reported sales totaled $896.73 million. Despite a 33.09% increase in earnings, the company... 
Via Benzinga
News headline image
Court Dismisses Canopy's Cannabis Patent Infringement Lawsuit Against Jazz's GW Pharma ↗
The U.S. District Court for the Western District of Texas dismissed a lawsuit filed by Canadian cannabis giant C... 
Via Benzinga
News headline image
Expert Ratings For Jazz Pharmaceuticals ↗
Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
News headline image
Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results ↗
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharma... 
Via Benzinga
News headline image
Jazz Pharmaceuticals: Q4 Earnings Insights ↗
Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
News headline image
This Company's 18-Month CBD Stability Achievement Could Hint Towards Expansion Goals As It Plans To Release First Commercial UST System In 2022 ↗
Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
News headline image
Does This Company's Recent CBD Breakthrough Earn It A Spot In The Guinness World Records? ↗
Photo by CBD Infos on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
News headline image
New Psychedelics ETF Launches On NYSE Arca ↗
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)... 
Via Benzinga
News headline image
The "Cannabis 50" List For 2021 Is Out, Is Your Favorite Company On It? ↗
MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list. 
Via Benzinga
News headline image
Jim Cramer Shares His Thoughts On ArcBest, Ulta Beauty And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes ArcBest Corporation (NASDAQ: 
Via Benzinga
News headline image
Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest ↗
The deal includes a CVS tied to Fintepla's next potential approval. 
Via Investor's Business Daily
News headline image
Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026 ↗
As the COVID-19 pandemic continues, the global market for cannabis beverages estimated at $799.8 million 2020, is projected to reach a revised... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... 
Via Benzinga
2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
Via AB Newswire
News headline image
A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones and S&P 500 closed at fresh highs on the first trading day of new year.... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.